Melanoma patients in England get fast-track access to cancer vaccine
Source: The Guardian, April 2025
Patients with an advanced type of skin melanoma in England will be given fast-track access to a “revolutionary” new cancer vaccine as part of an NHS trial.
The vaccine, known as iSCIB1+ (ImmunoBody), helps the immune system recognise cancer cells and therefore better respond to immunotherapy treatment.
The trial is part of the expansion of NHS England’s Cancer Vaccine Launch Pad (CVLP), a programme to fast-track eligible patients to studies developing vaccines at their nearest participating hospital.